Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
Gaspari
F
F
Department of Transplant Immunology and Innovative Antirejection Therapies, Ospedali Riuniti di Bergamo, Mario Negri Institute for Pharmacological Résearch, Italy.
Anedda
M F
MF
Signorini
O
O
Amuchastegui
S C
SC
Perico
N
N
Remuzzi
G
G
D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004304:Dosage Forms; D004359:Drug Therapy, Combination; D004655:Emulsions; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D012079:Renal Circulation / Q000187:drug effects; D013256:Steroids / Q000627:therapeutic use
D004304:Dosage Forms; D004655:Emulsions; D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine